Page last updated: 2024-08-24

capecitabine and Carcinoma, Transitional Cell

capecitabine has been researched along with Carcinoma, Transitional Cell in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's1 (25.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
A, R; Ahmed, S; El-Naggar, MS; Gamal, DA; Youssief, AA; Zarzor, MA1
An, X; Cao, Y; Chen, T; Deng, Y; Han, H; Shi, Y; Teng, X; Xue, C; Yang, W; Zhou, F1
Fontana, J; Forman, J; Frazier, A; Patel, B; Pontes, E; Vaishampayan, U1
Hartley, A; Ho, K; Muscroft, T; Sanghera, P1

Other Studies

4 other study(ies) available for capecitabine and Carcinoma, Transitional Cell

ArticleYear
Could Concurrent Capecitabine with Hypofractionated Radiotherapy in Elderly Patients with Muscle-Invasive Bladder Cancer be an Option?
    Asian Pacific journal of cancer prevention : APJCP, 2022, May-01, Volume: 23, Issue:5

    Topics: Aged; Aged, 80 and over; Capecitabine; Carcinoma, Transitional Cell; Humans; Muscles; Radiation Dose Hypofractionation; Urinary Bladder Neoplasms

2022
Effectiveness of capecitabine with or without docetaxel therapy for the treatment of patients with advanced urothelial carcinoma: a single-institution experience.
    Oncotarget, 2016, Sep-27, Volume: 7, Issue:39

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Carcinoma; Carcinoma, Transitional Cell; Disease-Free Survival; Docetaxel; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Palliative Care; Retrospective Studies; Taxoids; Treatment Outcome; Urinary Bladder Neoplasms; Urothelium

2016
A single institution experience with concurrent capecitabine and radiation therapy in weak and/or elderly patients with urothelial cancer.
    International journal of radiation oncology, biology, physics, 2005, Aug-01, Volume: 62, Issue:5

    Topics: Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Capecitabine; Carcinoma in Situ; Carcinoma, Transitional Cell; Combined Modality Therapy; Deoxycytidine; Female; Fluorouracil; Humans; Male; Middle Aged; Prodrugs; Radiotherapy Dosage; Urinary Bladder Neoplasms

2005
Neoadjuvant chemotherapy enables R0 resection of locally advanced rectal cancer in a patient with a previously irradiated pelvis.
    The British journal of radiology, 2007, Volume: 80, Issue:956

    Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Carcinoma, Transitional Cell; Colonic Pouches; Deoxycytidine; Fluorouracil; Humans; Magnetic Resonance Imaging; Male; Organoplatinum Compounds; Oxaliplatin; Prostatic Neoplasms; Rectal Neoplasms; Urinary Bladder Neoplasms

2007